Trial Profile
A single-centre retrospective study of capecitabine as a post-operative adjuvant therapy in patients with pancreatic or periampullary adenocarcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 06 Oct 2015 New trial record